Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
1 clinical trials · Condition
◉ Watch Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
| Record | Firm | Date |
|---|---|---|
| Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04815720) | Vaccinex Inc. | 2021-08-09 |
Track Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) automatically
Every clearance here is in the API, with alerts when new ones post.